As an industry segment, drug delivery was virtually created by two companies—Alza Corp. and Elan Corp. PLC . And for years, those two companies virtually owned the segment. Anyone with a drug delivery problem, who couldn't solve it alone, naturally went first to Alza or Elan. Technologically competent, financially stable, they were partners of choice.
But with their transformation into drug companies, the role of Alza and Elan as drug delivery technology providers has largely...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?